Tomoka Yoda

Epo-C12 inhibits peroxiredoxin 1 peroxidase activity.

K. Sakaguchi, A. Morita, F. Sugawara, 2021, Bioorganic & medicinal chemistry.

Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma

S. Ohnishi, M. Natsuizaka, T. Sho, 2023, Cancers.

Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight

S. Ohnishi, M. Natsuizaka, T. Sho, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma

S. Ohnishi, M. Natsuizaka, T. Sho, 2023, Cancers.

Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan.

S. Ohnishi, M. Natsuizaka, S. Komukai, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma

M. Natsuizaka, T. Sho, Koji Ogawa, 2023, Frontiers in nutrition.